Co-beneldopa (Benserazide/levodopa) vs Cabergoline
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 205.2× as often as Cabergoline in March 2026 — 79,414 items versus 387 in England.
79,414items
Co-beneldopa (Benserazide/levodopa) · March 2026
NHSBSA Prescription Cost Analysis
387items
Cabergoline · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Cabergoline: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Cabergoline
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Cabergoline |
|---|---|---|
| Items, March 2026 | 79,414 | 387 |
| Items, last 12 months | 949,699 | 4,180 |
| Net ingredient cost, March 2026 | £886,111 | £33,219 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Cabergoline.